EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes

Jiaqiang Xiong, Lu Dong, Qiongying Lv, Yutong Yin, Jiahui Zhao, Youning Ke, Shixuan Wang iD, Wei Zhang, Meng Wu iD

Clinical and Translational Medicine · 2024-09 · 14 (9)

DOI: 10.1002/ctm2.1772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 13.09.2024. Verfasst von Jiaqiang Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Senescence-Associated Secretory Phenotype, Neoplasms. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fund of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumour cell senescence can be induced by various factors, including DNA damage, inflammatory signals, genetic toxins, ionising radiation and nutrient metabolism. The senescence‐associated secretory phenotype (SASP), secreted by senescent tumour cells, possesses the capacity to modulate various immune cells, including macrophages, T cells, natural killer cells and myeloid‐derived suppressor cells, as well as vascular endothelial cells and fibroblasts within the tumour microenvironment (TME), and this modulation can result in either the promotion or suppression of tumorigenesis and progression. Exploring the impact of SASP on the TME could identify potential therapeutic targets, yet limited studies have dissected its functions. In this review, we delve into the causes and mechanisms of tumour cell senescence. We then concentrate on the influence of SASP on the tumour immune microenvironment, angiogenesis, extracellular matrix and the reprogramming of cancer stem cells, along with their associated tumour outcomes. Last, we present a comprehensive overview of the diverse array of senotherapeutics, highlighting their prospective advantages and challenge for the treatment of cancer patients. Key points Senescence‐associated secretory phenotype (SASP) secretion from senescent tumour cells significantly impacts cancer progression and biology. SASP is involved in regulating the remodelling of the tumour microenvironment, including immune microenvironment, vascular, extracellular matrix and cancer stem cells. Senotherapeutics, such as senolytic, senomorphic, nanotherapy and senolytic vaccines, hold promise for enhancing cancer treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentSenescence-Associated Secretory PhenotypeNeoplasmsHumansCellular Senescence

Stichwörter der Autor:innen

SASPcell senescencesenolytictumour microenvironment

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • The Second Clinical College of Wuhan University, Wuhan, China.
  • The First Clinical College of Wuhan University, Wuhan, China.
  • Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Shixuan Wang, Meng Wu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fund of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
  • Major Science and Technology Foundation of Hubei Province
  • Technology Research Project Foundation of Hubei Province
  • Program of Excellent Doctor of Zhongnan Hospital of Wuhan University

Zitieren

APA

Xiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024). Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes. Clinical and Translational Medicine, 14(9). https://doi.org/10.1002/ctm2.1772

Vancouver

Xiong J, Dong L, Lv Q, Yin Y, Zhao J, Ke Y, et al. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes. Clinical and Translational Medicine. 2024;14(9). doi:10.1002/ctm2.1772

BibTeX
@article{Xiong2024,
  author = {Xiong, Jiaqiang and Dong, Lu and Lv, Qiongying and Yin, Yutong and Zhao, Jiahui and Ke, Youning and Wang, Shixuan and Zhang, Wei and Wu, Meng},
  title = {Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {9},
  doi = {10.1002/ctm2.1772}
}
Kostenlos starten →